MANGOLYTICS, INC. – Trademark Portfolio
Entity Type: 03
MANGOLYTICS, INC. holds 6 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 9 (Computers & Electronics) — 6 filings in this category. The portfolio also extends into Class 42 (Computer & Scientific) across 4 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include SWINGVISION. The owner is based in Saratoga, CA.
12844 CUMBERLAND DRIVE
Saratoga, CA 95070
Showing of trademarks Trademarks
Trademark Classifications
MANGOLYTICS, INC.'s trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Scientific and technological services; industrial analysis and research services
Education; providing of training; entertainment; sporting and cultural activities
Frequently Asked Questions
How many trademarks does MANGOLYTICS, INC. have?
MANGOLYTICS, INC. has 6 U.S. trademarks filed with the USPTO. Of these, 1 registered, 1 abandoned, 4 cancelled.
What trademark classes does MANGOLYTICS, INC. file in?
MANGOLYTICS, INC. files trademarks across 4 Nice Classification classes. The most active classes are Class 9 (Computers & Electronics), Class 42 (Computer & Scientific), Class 41 (Education & Entertainment), Class 38 (Telecommunications). Class 9 covers scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments.
What are MANGOLYTICS, INC.'s most well-known trademarks?
MANGOLYTICS, INC.'s registered trademark portfolio includes well-known marks such as SWINGVISION. These are among 1 currently registered trademark in the portfolio.
What is MANGOLYTICS, INC.'s trademark registration success rate?
MANGOLYTICS, INC. has a 17% trademark registration rate, with 1 out of 6 resolved applications resulting in successful registration. Currently, 0 applications are pending review.